SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-24-037068
Filing Date
2024-08-13
Accepted
2024-08-13 16:06:42
Documents
80
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ef20030049_10q.htm   iXBRL 10-Q 1406753
2 EXHIBIT 3.1 ef20030049_ex3-1.htm EX-3.1 52539
3 EXHIBIT 10.1 ef20030049_ex10-1.htm EX-10.1 41608
4 EXHIBIT 31.1 ef20030049_ex31-1.htm EX-31.1 7914
5 EXHIBIT 31.2 ef20030049_ex31-2.htm EX-31.2 8051
6 EXHIBIT 32.1 ef20030049_ex32-1.htm EX-32.1 4929
  Complete submission text file 0001140361-24-037068.txt   7151103

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ocup-20240630.xsd EX-101.SCH 67383
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ocup-20240630_cal.xml EX-101.CAL 32682
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ocup-20240630_def.xml EX-101.DEF 293055
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocup-20240630_lab.xml EX-101.LAB 681544
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocup-20240630_pre.xml EX-101.PRE 434101
83 EXTRACTED XBRL INSTANCE DOCUMENT ef20030049_10q_htm.xml XML 1046177
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34079 | Film No.: 241201416
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)